Squalene synthase inhibitors

被引：21

作者：

Menys, VC ^{[1
]}

Durrington, PN ^{[1
]}

机构：

[1] Manchester Royal Infirm, Med & Surg Cent Clin Acad Grp, Manchester M13 9WL, Lancs, England

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2003年 / 139卷 / 05期

关键词：

TAK-475; hypercholesterolaemia; HMG-CoA reductase inhibitors; squalene synthase inhibitors; coronary heart disease;

D O I：

10.1038/sj.bjp.0705331

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：881 / 882

页数：2

共 13 条

[1]

Edwards PA, 2002, J LIPID RES, V43, P2

[2] Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway [J].

Edwards, PA ;

Ericsson, J .

ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :157-185

[3] Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro [J].

Flint, OP ;

Masters, BA ;

Gregg, RE ;

Durham, SK .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :91-98

[4] HMG CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture [J].

Flint, OP ;

Masters, BA ;

Gregg, RE ;

Durham, SK .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) :99-110

[5]

GAW A, 2000, STATINS HMG COA REDU, P47

[6]

GIBBONS GF, 1982, BIOCH CHOLESTEROL, P131

[7] CHOLESTEROL AND CORONARY HEART-DISEASE - A NEW ERA [J].

GRUNDY, SM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2849-2858

[8]

Gupta Eric K, 2002, Heart Dis, V4, P399, DOI 10.1097/00132580-200211000-00011

[9] CATARACTS IN PATIENTS TREATED WITH TRIPARANOL [J].

LAUGHLIN, RC ;

CAREY, TF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (04) :339-&

[10] Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients [J].

Miettinen, TA ;

Gylling, H .

ATHEROSCLEROSIS, 2002, 164 (01) :147-152

← 1 2 →